Literature DB >> 24166225

Empirical performance of the case-control method: lessons for developing a risk identification and analysis system.

David Madigan1, Martijn J Schuemie, Patrick B Ryan.   

Abstract

BACKGROUND: Considerable attention now focuses on the use of large-scale observational healthcare data for understanding drug safety. In this context, analysts utilize a variety of statistical and epidemiological approaches such as case-control, cohort, and self-controlled methods. The operating characteristics of these methods are poorly understood.
OBJECTIVE: Establish the operating characteristics of the case-control method for large scale observational analysis in drug safety. RESEARCH
DESIGN: We empirically evaluated the case-control approach in 5 real observational healthcare databases and 6 simulated datasets. We retrospectively studied the predictive accuracy of the method when applied to a collection of 165 positive controls and 234 negative controls across 4 outcomes: acute liver injury, acute myocardial infarction, acute kidney injury, and upper gastrointestinal bleeding.
RESULTS: In our experiment, the case-control method provided weak discrimination between positive and negative controls. Furthermore, the method yielded positively biased estimates and confidence intervals that had poor coverage properties.
CONCLUSIONS: For the four outcomes we examined, the case-control method may not be the method of choice for estimating potentially harmful effects of drugs.

Entities:  

Mesh:

Year:  2013        PMID: 24166225     DOI: 10.1007/s40264-013-0105-z

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  18 in total

1.  A Multiagent System for Integrated Detection of Pharmacovigilance Signals.

Authors:  Vassilis Koutkias; Marie-Christine Jaulent
Journal:  J Med Syst       Date:  2015-11-21       Impact factor: 4.460

2.  How Confident Are We about Observational Findings in Healthcare: A Benchmark Study.

Authors:  Martijn J Schuemie; M Soledad Cepeda; Marc A Suchard; Jianxiao Yang; Yuxi Tian; Alejandro Schuler; Patrick B Ryan; David Madigan; George Hripcsak
Journal:  Harv Data Sci Rev       Date:  2020-01-31

3.  Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databases.

Authors:  Martijn J Schuemie; Rosa Gini; Preciosa M Coloma; Huub Straatman; Ron M C Herings; Lars Pedersen; Francesco Innocenti; Giampiero Mazzaglia; Gino Picelli; Johan van der Lei; Miriam C J M Sturkenboom
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

Review 4.  Desideratum for evidence based epidemiology.

Authors:  J Marc Overhage; Patrick B Ryan; Martijn J Schuemie; Paul E Stang
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

5.  Variation in choice of study design: findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) survey.

Authors:  Paul E Stang; Patrick B Ryan; J Marc Overhage; Martijn J Schuemie; Abraham G Hartzema; Emily Welebob
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

6.  A comparison of the empirical performance of methods for a risk identification system.

Authors:  Patrick B Ryan; Paul E Stang; J Marc Overhage; Marc A Suchard; Abraham G Hartzema; William DuMouchel; Christian G Reich; Martijn J Schuemie; David Madigan
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

7.  Evaluating performance of risk identification methods through a large-scale simulation of observational data.

Authors:  Patrick B Ryan; Martijn J Schuemie
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

8.  Adverse Drug Reaction Discovery from Electronic Health Records with Deep Neural Networks.

Authors:  Wei Zhang; Peggy Peissig; Zhaobin Kuang; David Page
Journal:  Proc ACM Conf Health Inference Learn (2020)       Date:  2020-04

9.  Pharmacovigilance via Baseline Regularization with Large-Scale Longitudinal Observational Data.

Authors:  Zhaobin Kuang; Peggy Peissig; Vítor Santos Costa; Richard Maclin; David Page
Journal:  KDD       Date:  2017-08

Review 10.  Defining a reference set to support methodological research in drug safety.

Authors:  Patrick B Ryan; Martijn J Schuemie; Emily Welebob; Jon Duke; Sarah Valentine; Abraham G Hartzema
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.